ATE389711T1 - Ein in vitro modell der tumorangiogenese - Google Patents

Ein in vitro modell der tumorangiogenese

Info

Publication number
ATE389711T1
ATE389711T1 AT04103880T AT04103880T ATE389711T1 AT E389711 T1 ATE389711 T1 AT E389711T1 AT 04103880 T AT04103880 T AT 04103880T AT 04103880 T AT04103880 T AT 04103880T AT E389711 T1 ATE389711 T1 AT E389711T1
Authority
AT
Austria
Prior art keywords
tumor angiogenesis
vitro model
endothelial cells
normal endothelial
tumor
Prior art date
Application number
AT04103880T
Other languages
English (en)
Inventor
Min Wu
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE389711T1 publication Critical patent/ATE389711T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04103880T 2003-08-14 2004-08-12 Ein in vitro modell der tumorangiogenese ATE389711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49542903P 2003-08-14 2003-08-14
US91290404A 2004-08-06 2004-08-06

Publications (1)

Publication Number Publication Date
ATE389711T1 true ATE389711T1 (de) 2008-04-15

Family

ID=33567982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04103880T ATE389711T1 (de) 2003-08-14 2004-08-12 Ein in vitro modell der tumorangiogenese

Country Status (4)

Country Link
EP (1) EP1506998B1 (de)
JP (1) JP4993539B2 (de)
AT (1) ATE389711T1 (de)
DE (1) DE602004012498T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687263B2 (en) 2005-05-11 2010-03-30 Becton, Dickinson And Company In vitro tumor angiogenesis model
US8192949B2 (en) 2005-12-16 2012-06-05 Weisenthal Larry M Microaggregates including endothelial cells
GB201100180D0 (en) * 2011-01-06 2011-02-23 Capsant Neurotechnologies Ltd Tumour cell and tissue culture
CN113308434B (zh) * 2021-05-31 2022-10-04 中山大学孙逸仙纪念医院 一种用于研究管形成的内皮细胞和周细胞共培养模型的构建方法

Also Published As

Publication number Publication date
DE602004012498T2 (de) 2009-04-09
JP2005058237A (ja) 2005-03-10
JP4993539B2 (ja) 2012-08-08
DE602004012498D1 (de) 2008-04-30
EP1506998A1 (de) 2005-02-16
EP1506998B1 (de) 2008-03-19

Similar Documents

Publication Publication Date Title
CY1107018T1 (el) Τεχνητο ανοσο οργανο
ATE523489T1 (de) 3'-alkoxy spirocyclische tetram- und tetronsäuren
NO20042769L (no) Fremgangsmate for a pavise humant papillomavirus-mRNA
DK1367008T3 (da) Skab med kontrolleret luftcirkulation
NZ569543A (en) Means and methods for influencing the stability of antibody producing cells
ATE534728T1 (de) Nestinexprimierende haarfollikelstammzellen
AU308407S (en) Applicator
DE60317658D1 (de) Polstermaterial mit dichtegradient und verfahren zu dessen herstellung
DE60233825D1 (de) BENZOATESÄURE-2-(a-HYDROXYPENTYL)ESTER UND DESSEN HERSTELLUNG UND VERWENDUNG
DE602006019611D1 (de) Neues künstliches basenpaar und verwendung davon
DE60323196D1 (de) Spannungsversorgung mit mehreren Versorgungspannungen
ATE413139T1 (de) Vorrichtung zur herstellung von anastomosen zwischen hohlorganen
DE60025851D1 (de) Spielzeug mit luftballon und beleuchtungsgerät
DE60118607D1 (de) Rolltreppe mit stufenflansch
NO20030112L (no) Lettflytende polyester-formmasse
DE602006018787D1 (de) Kegelförmiger flügel mit tragflächenbereichen mit entgegengesetzten wirkungen und konstantem antrieb
ATE389711T1 (de) Ein in vitro modell der tumorangiogenese
DE60329077D1 (de) Flugzeugflügel
FR2872592B1 (fr) Chaine amplificatrice pour la generation d'impulsions lumineuses ultracourtes de durees d'impulsions differentes
DE60323034D1 (de) Form zur Herstellung von Modell und Modell zum Feingiessen
DE60134887D1 (de) Neues kakaoalbumin und seine verwendung bei der er
CN203567440U (zh) 一种透明内雕式发光画
DE602004011730D1 (de) Verfahren zur Herstellung von Valsartan
ITMC20020090A1 (it) Biciclo volante con passaggio delle due spinte negative in positive
KR20120008128U (ko) 형상이 변형되는 알람시계

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1506998

Country of ref document: EP